<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The chemokine CXCL14 has been reported to play an important role in the progression of many <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> such as <z:hpo ids='HP_0003002'>breast cancer</z:hpo> and <z:hpo ids='HP_0002895'>papillary thyroid carcinoma</z:hpo>, but the role of CXCL14 in colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) remains to be established </plain></SENT>
<SENT sid="1" pm="."><plain>The purpose of this study was to investigate the expression pattern and significance of CXCL14 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> progression </plain></SENT>
<SENT sid="2" pm="."><plain>METHOD: 265 colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> specimens and 129 matched adjacent <z:mpath ids='MPATH_458'>normal</z:mpath> colorectal mucosa specimens were collected </plain></SENT>
<SENT sid="3" pm="."><plain>Expression of CXCL14 in clinical samples was examined by immunostaining </plain></SENT>
<SENT sid="4" pm="."><plain>The effect of CXCL14 on colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> cell proliferation was measured by <z:chebi fb="0" ids="53233">MTT</z:chebi> assay, BrdU incorporation assay and colony formation assay </plain></SENT>
<SENT sid="5" pm="."><plain>The impact of CXCL14 on migration and invasion of colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> cells was determined by transwell assay and Matrigel invasion assay, respectively </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: CXCL14 expression was significantly up-regulated in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissues compared with adjacent nontumorous mucosa tissues (P &lt; 0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>Tumoral CXCL14 expression levels were significantly correlated with TNM (<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e>-node-<z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>) stage, histodifferentiation, and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> size </plain></SENT>
<SENT sid="8" pm="."><plain>In multivariate Cox regression analysis, high CXCL14 expression in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> specimens (n = 91) from stage I/II patients was associated with increased risk for disease recurrence (risk ratio, 2.92; 95% CI, 1.15-7.40; P = 0.024) </plain></SENT>
<SENT sid="9" pm="."><plain>Elevated CXCL14 expression in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> specimens (n = 135) from stage III/IV patients correlated with worse overall survival (risk ratio, 3.087; 95% CI, 1.866-5.107; P &lt; 0.001) </plain></SENT>
<SENT sid="10" pm="."><plain>Functional studies demonstrated that enforced expression of CXCL14 in SW620 colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> cells resulted in more aggressive phenotypes </plain></SENT>
<SENT sid="11" pm="."><plain>In contrast, knockdown of CXCL14 expression could mitigate the proliferative, migratory and invasive potential of HCT116 colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> cells </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSION: Taken together, CXCL14 might be a potential novel prognostic factor to predict the disease recurrence and overall survival and could be a potential target of postoperative adjuvant therapy in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients </plain></SENT>
</text></document>